PMPN_Pharmaceutical & Medical Packaging News

Pharmaceutical & Medical Packaging News, May/June 2015

Issue link:

Contents of this Issue


Page 11 of 43

News • Pharmaceutical & Medical Packaging News May/June 2015 12 design in titrating patients through their drug regimen, progressing them to the target dose. Color coding out- lines dosing, identifying the starting dose of 18 mg and continuing for the first five days of therapy, progressing to 25 mg for the following mve days, 40 mg for the next five, and reaching 60 mg. Other versions of the titration dosing utilize a 10/18/25/40 mg format, 25/40/60/80 mg, depending on the weight of the patient. Each strength combination is denoted by a unique color configuration and identifies the recommended weight guidelines for the therapy. The package also features a multi-panel label ofering dosing instructions, patient education, and tips to avoid side efects and identifying optimal daily timing for doses, along with its boxed warning and safety information. A patient information leaflet is also included for the patient in the cover panel of the Strattera Sample Pack. One judge stated that "from a compliance/adherence perspective, this package ofers impressive benefits. First, it ofers graphic appeal and does a superb job of using easy- to-read type that should make it easily readable, even for seniors who might be helping to administer the capsules to children and adolescents. An easy-open carton front folds up, revealing essentially two additional panels. Treatment instructions are adhered to the top inner portion of the carton. Simple two-step opening instructions on the other inner carton panel yield access to target doses. Each blister is clearly marked with the dosage date in a folding pullout that's easy to fold back into the primary carton. Much thought was put into the design on this pack, which func- tions easily for patients." The second runner-up is the packaging for Novartis Exforge HCT (amlodipine, valsartan, hydrocholorothia- zide), which is indicated for the treatment of high blood pressure. Packaged by PCI for Novartis, the Exforge HCT blister package uses the MWV Shellpak Renew child- resistant design. According to HCPC, package graphics highlight the calendarized format, and colorful graphics on the primary blister unit employ colorful graphics to iden- tify the starting dose and each daily dose as well as remind patients when the time to refill the prescription is approach- ing. Other adherence tools featured include a patient sav- ings card to support patients with script fills as well as suggestions for the patient to visit the website and join the Get On Track program. Also provided is the prescribing information leaflet. "The blister does a good job of delineating separate weeks through color and does a good job of including 4 weeks of therapy in one blister package extending compli- ance packaging to maintenance therapy, which should have an impact on adherence," one of the industry judges stated. The Compliance Package of the Year winner and the First Runner-up will be asked to designate HCPC donated scholarship funds to a university-level packaging school focused on the pharmaceutical industry. For more information on HCPC, please visit www. The 2014 HCPC Compliance Package of the Year Second Runner-Up: Novartis Exforge HCT, in the MWV Shellpak Renew, packaged by PCI.

Articles in this issue

Links on this page

Archives of this issue

view archives of PMPN_Pharmaceutical & Medical Packaging News - Pharmaceutical & Medical Packaging News, May/June 2015